Chemotherapy of testis cancer: A review (Q36725720)

15 August 2017

1 reference

title

Chemotherapy of testis cancer: a review (English)

1 reference

15 August 2017

Chemotherapy of testis cancer: A review (English)

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91002-5

9 November 2022

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91002-5

9 November 2022

author name string

S. D. Williams

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1727120

9 November 2022

B. J. Roth

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1727120

9 November 2022

language of work or name

English

0 references

publication date

1 January 1992

1 reference

full work available at URL

15 August 2017

https://api.elsevier.com/content/article/PII:0360301692910025?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91002-5

https://api.elsevier.com/content/article/PII:0360301692910025?httpAccept=text/plain

9 November 2022

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91002-5

International Journal of Radiation Oncology Biology Physics

9 November 2022

published in

1 reference

15 August 2017

volume

22

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

213-217

1 reference

The management of metastatic seminoma testis

15 August 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91002-5

Prognostic factors for favorable outcome in disseminated germ cell tumors

9 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91002-5

A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors

9 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91002-5

VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors

9 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91002-5

Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer

9 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91002-5

Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer

9 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91002-5

Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol

9 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91002-5

The role of maintenance therapy in disseminated testicular cancer

9 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91002-5

Simple nontoxic treatment of advanced metastatic seminoma with carboplatin

9 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91002-5

Chemotherapy of metastatic seminoma: the Southeastern Cancer Study Group experience

9 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91002-5

Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: a clinicopathological correlation

9 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91002-5

Testicular cancer: the quest continues

9 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91002-5

Advanced seminoma: the role of chemotherapy and adjunctive surgery

9 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91002-5

A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors

9 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91002-5

Management of postchemotherapy residual mass in patients with advanced seminoma: Indiana University experience

9 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91002-5

Brain metastases and testicular tumors: long-term survival

9 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91002-5

Seminoma of the testis: results of treatment and patterns of failure after radiation therapy

9 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91002-5

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide

9 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)91002-5

9 November 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1727120

9 November 2022

1 reference